What happens when we convince ourselves we're different, special, exempt from the rules that bind everyone else?
The FDA approved Rejoyn, the first prescription app for depression. Here's what the clinical data reveals about its effectiveness and limitations.
Donanemab slows Alzheimer's progression by 35% and clears plaques in 12-18 months. Learn who benefits, costs, risks, and what this means for families.
A 2024 Cleveland Clinic study links xylitol to triple the heart attack risk. What this means for the millions using sugar-free products daily.
Microsoft's CEO reflects on the paradox of building trust in AI: you must use it first, then learn to protect against its risks.
A reflection on evolution, technology, and the terror of transformation, inspired by cinema's most enigmatic odyssey.
Comcast's StreamSaver bundle marks streaming's shift from competition to collaboration, offering Netflix, Peacock, and Apple TV+ for $15 monthly.
Maya Angelou explains to Oprah why courage is essential for practicing any other virtue consistently in life.
A 2024 JAMA study linked intermittent fasting to 91% higher heart risk. But the real story involves missing context, study design flaws, and nuance.
New research from Zoe reveals how gut bacteria composition may influence menopause symptom severity, offering women a new approach to managing transitions.
